Circulating cervical cancer biomarkers potentially useful in medical attention (Review)
- Authors:
- Ruth Ruiz Esparza Garrido
- Mercedes Gutiérrez
- Miguel Ángel Velázquez Flores
-
Affiliations: Investigadora por México, Non-coding RNAs Laboratory, Medical Research Unit in Human Genetics, Children's Hospital ‘Dr. Silvestre Frenk Freund’, National Medical Center XXI Century, Mexican Institute of Social (Instituto Mexicano del Seguro Social, IMSS), Doctores, Mexico City 06720, Mexico, ATSO PHARMA Laboratory, Jardines del Pedregal, Álvaro Obregón, Mexico City 01900, Mexico, Non-coding RNAs Laboratory, Medical Research Unit in Human Genetics, Children's Hospital ‘Dr. Silvestre Frenk Freund’, National Medical Center XXI Century, Mexican Institute of Social (Instituto Mexicano del Seguro Social, IMSS), Doctores, Mexico City 06720, Mexico - Published online on: January 18, 2023 https://doi.org/10.3892/mco.2023.2609
- Article Number: 13
-
Copyright: © Ruiz Esparza Garrido et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
|
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Lee SI and Atri M: 2018 FIGO staging system for uterine cervical cancer: Enter cross-sectional imaging. Radiology. 292:15–24. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Cho H, Oh CK, Cha J, Chung JI, Byun SS, Hong SK, Chung JS and Han KH: Association of serum prostate-specific antigen (PSA) level and circulating tumor cell-based PSA mRNA in prostate cancer. Prostate Int. 10:14–20. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Nieder C, Dalhaug A and Mannsåker B: Established serum biomarkers are prognostic factors in patients with oligometastatic cancer and brain involvement. In Vivo. 36:801–805. 2022.PubMed/NCBI View Article : Google Scholar | |
|
López-Aguilar JE, Velázquez-Flores MA, Simón-Martínez LA, Ávila-Miranda R, Rodríguez-Florido MA and Ruiz-Esparza Garrido R: Circulating microRNAs as biomarkers for pediatric astrocytomas. Arch Med Res. 48:323–332. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Zheng S, Li R, Liang J, Wen Z, Huang X, Du X, Dong S, Zhu K, Chen X, Liu D, et al: Serum miR-638 combined with squamous cell carcinoma-related antigen as potential screening biomarkers for cervical squamous cell carcinoma. Genet Test Mol Biomarkers. 24:188–194. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Jia W, Wu Y, Zhang Q, Gao GE, Zhang C and Xiang Y: Expression profile of circulating microRNAs as a promising fingerprint for cervical cancer diagnosis and monitoring. Mol Clin Oncol. 3:851–858. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Qiu H, Liang D, Liu L, Xiang Q, Yi Z and Ji Y: A novel circulating MiRNA-based signature for the diagnosis and prognosis prediction of early-stage cervical cancer. Technol Cancer Res Treat. 19(1533033820970667)2020.PubMed/NCBI View Article : Google Scholar | |
|
ACCP. Pap smears: An important but imperfect method. Cervical Cancer Prevention Fact Sheet, 2002. | |
|
Milla Villeda RH, Alvarado Zaldívar G, Sánchez Anguiano LF, Barrera Tovar M and Vázquez Arreola I: Colposcopy and cervical biopsy in patients with routine Papanicolaou smear. Ginecol Obstet Mex. 65:235–238. 1997.PubMed/NCBI | |
|
Chu E, Bratwaite O, Gonzalez I, Campo Z and De León RG: Diagnosis of human papillomavirus by Papanicolau and PCR in a group of adolescents and young women. Instituto conmemorativo gorgas de estudios de la salud, centro de investigación en reproducción humana. URL: Microsoft Word-2087_2002_doc(gorgas.gob.pa). | |
|
Flores-Juárez DJ and García-González GA: Usefulness of Papanicolau for cervical dysplasia in patients HPV positive with CD4 <200 cell/mm3. Escuela de Estudios de Postgrado de la Facultad de Ciencias Médicas Maestría en Ginecología y Obstetricia Tesis para obtener el grado de Maestras en Ciencias en Ginecología y Obstetricia, pp1-45, 2014. URL: https://biblioteca.medicina.usac.edu.gt/tesis/post/2014/071.pdf. | |
|
Terrádez Raro JJ, Coloma Colomer F, Navarro Conde P and Gasull Ibáñez J: Cervical cancer screening in public health system in Valencia community and Pap test limit. Rev ESP Patol. 38:3–7. 2005. | |
|
Dzul-Rosado KR, Puerto-Solís M and González Losa MR: Cáncer cervicouterino: Métodos actuales para su detección. Rev Biomed. 15:233–241. 2004. | |
|
Vlastos AT, Richards-Kortum R, Zuluaga A and Follen M: New approaches to cervical cancer screening. Contemporary Ob/Gyn. 47:87–107. 2002. | |
|
Andrade AZ, Zaragoza JZ, Blanco BR and Marañón RT: Evaluación del papanicolaou y la colposcopia en el diagnóstico de la infección por el virus del papiloma humano. Rev Fac Med UNAM. 44:5–7. 2001. | |
|
Granados-García V, Flores YN, Pérez R, Rudolph SE, Lazcano-Ponce E and Salmerón J: Cost of the cervical cancer screening program at the mexican social security institute. Salud Publica Mex. 56:502–510. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Solares LF, Álvarez AM, García-Echeverría AM and Velasco MJ: Diagnóstico citológico de ASCUS. Identificación del riesgo para displasia cervical mediante test del virus del papiloma humano. Clin Invest Ginecol Obstet. 32:50–53. 2005. | |
|
Zhang Q, Kuhn L, Denny LA, De Souza M, Taylor S and Wright TC Jr: Impact of utilizing p16INK4A immunohistochemistry on estimated performance of three cervical cancer screening tests. Int J Cancer. 120:351–356. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Mattosinho de Castro Ferraz Mda G, Nicolau SM, Stávale JN, Focchi J, Castelo A, Dôres GB, Mielzynska-Lohnas I, Lorincz A and Rodrigues de Lima G: Cervical biopsy-based comparison of a new liquid-based thin-layer preparation with conventional Pap smears. Diagn Cytopathol. 30:220–226. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Mitsuhashi A, Matsui H, Usui H, Nagai Y, Tate S, Unno Y, Hirashiki K, Seki K and Shozu M: Serum YKL-40 as a marker for cervical adenocarcinoma. Ann Oncol. 20:71–77. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Xu G, Fan W, Wang F, Lu H, Xing X, Zhang R and Jiang P: CTHRC1 as a novel biomarker in the diagnosis of cervical squamous cell carcinoma. Int J Clin Exp Pathol. 11:847–854. 2018.PubMed/NCBI | |
|
Yang SH, Wang XL, Cai J and Wang SH: Diagnostic value of circulating PIGF in combination with Flt-1 in early cervical cancer. Curr Med Sci. 40:973–978. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Sidorkiewicz I, Zbucka-Krętowska M, Zaręba K, Lubowicka E, Zajkowska M, Szmitkowski M, Gacuta E and Ławicki S: Plasma levels of M-CSF and VEGF in laboratory diagnostics and differentiation of selected histological types of cervical cancers. BMC Cancer. 19(398)2019.PubMed/NCBI View Article : Google Scholar | |
|
Ning R, Meng S, Wang L, Jia Y, Tang F, Sun H, Zhang Z, Zhang C, Fan X, Xiao B, et al: 6 Circulating miRNAs can be used as non-invasive biomarkers for the detection of cervical lesions. J Cancer. 12:5106–5113. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Chen J, Yao D, Li Y, Chen H, He C, Ding N, Lu Y, Ou T, Zhao S, Li L and Long F: Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma. Int J Mol Med. 32:557–567. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Sun W, Wang L, Zhao D, Wang P, Li Y and Wang S: Four circulating long non-coding RNAs Act as biomarkers for predicting cervical cancer. Gynecol Obstet Invest. 83:533–539. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Wang WJ, Wang D, Zhao M, Sun XJ, Li Y, Lin H, Che YQ and Huang CZ: Serum lncRNAs (CCAT2, LINC01133, LINC00511) with squamous cell carcinoma antigen panel as novel non-invasive biomarkers for detection of cervical squamous carcinoma. Cancer Manag Res. 12:9495–9502. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Rungkamoltip P, Temisak S, Piboonprai K, Japrung D, Thangsunan P, Chanpanitkitchot S, Chaowawanit W, Chandeying N, Tangjitgamol S and lempridee T: Rapid and ultrasensitive detection of circulating human papillomavirus E7 cell-free DNA as a cervical cancer biomarker. Exp Biol Med (Maywood). 246:654–666. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Gadducci A, Tana R, Cosio S and Genazzani AR: The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: A review of the literature. Crit Rev Oncol Hematol. 66:10–20. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Duffy MJ: Evidence for the clinical use of tumor markers. Ann Clin Biochem. 41:370–377. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Uemera Y, Pak SC, Luke C, Cataltepec S, Tsu C, Schick C, Kamachi Y, Pomeroy SL, Perlmutter DH and Silverman GA: Circulating serpin tumor markers SCCA1 and SCCA2 are not actively secreted but reside in the cytosol of squamous carcinoma cells. Int J Cancer. 89:368–377. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Numa F, Takeda O, Nakata M, Nawata S, Tsunaga N, Hirabayashi K, Suminami Y, Kato H and Hamanaka S: Tumor necrosis factor-alpha stimulates the production of squamous cell carcinoma antigen in normal squamous cells. Tumour Biol. 17:97–101. 1996.PubMed/NCBI View Article : Google Scholar | |
|
Liposits G, Skuladottir H, Ryg J, Winther SB, Möller S, Hofsli E, Shah CH, Poulsen LØ, Berglund Å, Qvortrup C, et al: The prognostic value of pre-treatment circulating biomarkers of systemic inflammation (CRP, dNLR, YKL-40, and IL-6) in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy-the randomized NORDIC9-study. J Clin Med. 11(5603)2022.PubMed/NCBI View Article : Google Scholar | |
|
Dolin TG, Christensen IJ, Lund CM, Bojesen SE, Lykke J, Nielsen DL, Larsen JS and Johansen JS: Preoperative plasma vitamin D in patients with localized colorectal cancer: Age-dependent association with inflammation, postoperative complications, and survival. Eur J Surg Oncol. (S0748-7983(22)00651-5)2022.PubMed/NCBI View Article : Google Scholar : (Epub ahead of print). | |
|
Rathcke CN and Vestergaard H: YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis. Inflamm Res. 55:221–227. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Bao J, Ouyang Y, Qiao L, He J, Liu F, Wang Y, Miao L, Fu A, Lou Z, Zang Q, et al: Serum CHI3L1 as a biomarker for non-invasive diagnosis of liver fibrosis. Discov Med. 33:41–49. 2022.PubMed/NCBI | |
|
Shi M, Ge Q, Wang X, Diao W, Yang B, Sun S, Wang G, Liu T, Chan AML, Gao Z, et al: Functional analysis of the short splicing variant encoded by CHI3L1/YKL-40 in glioblastoma. Front Oncol. 12(910728)2022.PubMed/NCBI View Article : Google Scholar | |
|
Videmark AN, Christensen IJ, Feltoft CL, Villadsen M, Borg FH, Jørgensen BM, Bojesen SE, Kistorp C, Ugleholdt R and Johansen JS: Combined plasma C-reactive protein, interleukin 6 and YKL-40 for detection of cancer and prognosis in patients with serious nonspecific symptoms and signs of cancer. Cancer Med: Nov 28, 2022 (Epub ahead of print). | |
|
Hermunen K, Soveri LM, Boisen MK, Mustonen HK, Dehlendorff C, Haglund CH, Johansen JS and Osterlund P: Postoperative serum CA19-9, YKL-40, CRP and IL-6 in combination with CEA as prognostic markers for recurrence and survival in colorectal cancer. Acta Oncol. 59:1416–1423. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Sheng X, Du X, Zhang X, Li D, Lu C, Li Q, Ma Z, Song Q and Wang C: Clinical value of serum HMGB1 levels in early detection of recurrent squamous cell carcinoma of uterine cervix: Comparison with serum SCCA, CYFRA21-1, and CEA levels. Croat Med J. 50:455–464. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Chen Y, Xiong X, Wang Y, Zhao J, Shi H, Zhang H, Wang Y, Wei Y, Xue W and Zhang J: Proteomic screening for serum biomarkers for cervical cancer and their clinical significance. Med Sci Monit. 25:288–297. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Zhu B, Dong B, Hong S, Wang M, Dai W, Zheng Q, Wu D and Cao Y: Combined detection of ACTN4 and SCC-Ag is a promising serological biomarker for cervical intraepithelial neoplasia 3 or worse: A case-control study. Risk Manag Health Policy. 13:2677–2687. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, et al: Initial sequencing and analysis of the human genome. Nature. 409:860–921. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Wang F, Sun H, Li K, Yang K, Xiang Y and Tian X: CircRASSF2 promotes IGF1R and osteosarcoma metastasis via sponging miR-6838-5p. Ann Transl Med. 10(11)2022.PubMed/NCBI View Article : Google Scholar | |
|
Gupta A, Vats A, Ghosal A, Mandal K, Sarkar R, Bhattacharya I, Das S, Pal R and Majumdar SS: Follicle-stimulating hormone-mediated decline in miR-92a-3p expression in pubertal mice Sertoli cells is crucial for germ cell differentiation and fertility. Cell Mol Life Sci. 79(136)2022.PubMed/NCBI View Article : Google Scholar | |
|
Bartel DP: Metazoan MicroRNAs. Cell. 173:20–51. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Hansen TB, Venø MT, Jensen TI, Schaefer A, Damgaard CK and Kjems J: Argonaute-associated short introns are a novel class of gene regulators. Nat Commun. 7(11538)2016.PubMed/NCBI View Article : Google Scholar | |
|
Vincent K, Pichler M, Lee GW and Ling H: MicroRNAs, genomic instability and cancer. Int J Mol Sci. 15:14475–14491. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Fabian MR, Sonenberg N and Filipowicz W: Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem. 79:351–379. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Liu H, Lei C, He Q, Pan Z, Xiao D and Tao Y: Nuclear functions of mammalian MicroRNAs in gene regulation, immunity and cancer. Mol Cancer. 17(64)2018.PubMed/NCBI View Article : Google Scholar | |
|
Leucci E, Patella F, Waage J, Holmstrøm K, Lindow M, Porse B, Kauppinen S and Lund AH: microRNA-9 targets the long non-coding RNA MALAT1 for degradation in the nucleus. Sci Rep. 3(2535)2013.PubMed/NCBI View Article : Google Scholar | |
|
Zitzer NC, Garzon R and Ranganathan P: Toll-like receptor stimulation by MicroRNAs in acute graft-vs-host disease. Front Immunol. 9(2561)2018.PubMed/NCBI View Article : Google Scholar | |
|
Zhao S, Yao D, Chen J and Ding N: Circulating miRNA-20a and miRNA-203 for screening lymph node metastasis in early stage cervical cancer. Genet Test Mol Biomarkers. 17:631–636. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Ma Q, Wan G, Wang S, Yang W, Zhang J and Yao X: Serum microRNA-205 as a novel biomarker for cervical cancer patients. Cancer Cell Int. 14(81)2014.PubMed/NCBI View Article : Google Scholar | |
|
Kong Q, Tang Z, Xiang F, Jiang J, Yue H, Wu R and Kang X: Diagnostic value of serum hsa-mir-92a in patients with cervical cancer. Clin Lab. 63:335–340. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Hoelzle CR, Arnoult S, Borém CRM, Ottone M, de Magalhaes KCSF, da Silva IL and Simoes RT: MicroRNA levels in cervical cancer samples and relationship with lesion grade and HPV infection. Microrna. 10:139–145. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Zhang Y, Qiu S, Guo Y, Zhang J, Wu X and Hong G: Diagnostic value of vaginal microecology, serum miR-18a, and PD-L1 for identifying HPV-positive cervical cancer. Technol Cancer Res Treat. 20(1533033821995281)2021.PubMed/NCBI View Article : Google Scholar | |
|
Cai Y, Zhang K, Cao L, Sun H and Wang H: Inhibition of microrna-766-5p attenuates the development of cervical cancer through regulating SCAI. Technol Cancer Res Treat. 19(1533033820980081)2020.PubMed/NCBI View Article : Google Scholar | |
|
Ocadiz-Delgado R, Lizcano-Meneses S, Trejo-Vazquez JA, Conde-Perezprina JC, Garrido-Palmas F, Alvarez-Rios E, García-Villa E, Ruiz G, Illades-Aguiar B, Leyva-Vázquez MA, et al: Circulating miR-15b, miR-34a and miR-218 as promising novel early low-invasive biomarkers of cervical carcinogenesis. APMIS. 129:70–79. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Yang D and Zhang Q: miR-152 may function as an early diagnostic and prognostic biomarker in patients with cervical intraepithelial neoplasia and patients with cervical cancer. Oncol Lett. 17:5693–5698. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Ding N, Lu Y, Zhu SL, Zhao S, Chen JY, He CJ, Ren F and Yao DS: MiR-17 promotes cervical squamous cell tumorigenesis and metastasis by targeting E2F1. Int J Clin Exp Pathol. 9:10224–10232. 2016. | |
|
Shukla V, Varghese VK, Kabekkodu SP, Mallya S, Chakrabarty S, Jayaram P, Pandey D, Banerjee S, Sharan K and Satyamoorthy K: Enumeration of deregulated miRNAs in liquid and tissue biopsies of cervical cancer. Gynecol Oncol. 155:135–143. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Pulati N, Zhang Z, Gulimilamu A, Qi X and Yang J: HPV16+ -miRNAs in cervical cancer and the anti-tumor role played by miR-5701. J Gene Med. 21(e3126)2019.PubMed/NCBI View Article : Google Scholar | |
|
Zhou CF, Ma J, Huang L, Yi HY, Zhang YM, Wu XG, Yan RM, Liang L, Zhong M, Yu YH, et al: Cervical squamous cell carcinoma-secreted exosomal miR-221-3p promotes lymphangiogenesis and lymphatic metastasis by targeting VASH1. Oncogene. 38:1256–1268. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Zhu X, Long L, Xiao H and He X: Cancer-derived exosomal miR-651 as a diagnostic marker restrains cisplatin resistance and directly targets ATG3 for cervical cancer. Dis Markers. 2021(1544784)2021.PubMed/NCBI View Article : Google Scholar | |
|
Yamanaka Z, Sasaki T, Yamanaka A, Kato K and Nishi H: Circulating and tissue miR-100 acts as a potential diagnostic biomarker for cervical cancer. Cancer Biomark. 32:551–558. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Lv A, Tu Z, Huang Y, Lu W and Xie B: Circulating exosomal miR-125a-5p as a novel biomarker for cervical cancer. Oncol Lett. 21(54)2021.PubMed/NCBI View Article : Google Scholar | |
|
Zheng M, Hou L, Ma Y, Zhou L, Wang F, Cheng B, Wang W, Lu B, Liu P, Lu W and Lu Y: Exosomal let-7d-3p and miR-30d-5p as diagnostic biomarkers for non-invasive screening of cervical cancer and its precursors. Mol Cancer. 18(76)2019.PubMed/NCBI View Article : Google Scholar | |
|
Zhang Y, Zhang D, Wang F, Xu D, Guo Y and Cui W: Serum miRNAs panel (miR-16-2*, miR-195, miR-2861, miR-497) as novel non-invasive biomarkers for detection of cervical cancer. Sci Rep. 5(17942)2015.PubMed/NCBI View Article : Google Scholar | |
|
Xin F, Liu P and Ma CF: A circulating serum miRNA panel as early detection biomarkers of cervical intraepithelial neoplasia. Eur Rev Med Pharmacol Sci. 20:4846–4851. 2016.PubMed/NCBI | |
|
Wang WT, Zhao YN, Yan JX, Weng MY, Wang Y, Chen YQ and Hong SJ: Differentially expressed microRNAs in the serum of cervical squamous cell carcinoma patients before and after surgery. J Hematol Oncol. 7(6)2014.PubMed/NCBI View Article : Google Scholar | |
|
Subhash S, Mishra K, Akhade VS, Kanduri M, Mondal T and Kanduri C: H3K4me2 and WDR5 enriched chromatin interacting long non-coding RNAs maintain transcriptionally competent chromatin at divergent transcriptional units. Nucleic Acids Res. 46:9384–9400. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Montero JJ, López-Silanes I, Megías D, F Fraga M, Castells-García Á and Blasco MA: TERRA recruitment of polycomb to telomeres is essential for histone trymethylation marks at telomeric heterochromatin. Nat Commun. 9(1548)2018.PubMed/NCBI View Article : Google Scholar | |
|
Kallen AN, Zhou XB, Xu J, Qiao C, Ma J, Yan L, Lu L, Liu C, Yi JS, Zhang H, et al: The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell. 52:101–112. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Li J, Wang Y, Yu J, Dong R and Qiu H: A high level of circulating HOTAIR is associated with progression and poor prognosis of cervical cancer. Tumour Biol. 36:1661–1665. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Catanzaro JM, Guerriero JL, Liu J, Ullman E, Sheshadri N, Chen JJ and Zong WX: Elevated expression of squamous cell carcinoma antigen (SCCA) is associated with human breast carcinoma. PLoS One. 6(e19096)2011.PubMed/NCBI View Article : Google Scholar | |
|
Qiao D, Qin X, Yang H, Liu X, Liu L, Liu S and Jia Z: Estradiol mediates the interaction of LINC01541 and miR-429 to promote angiogenesis of G1/G2 endometrioid adenocarcinoma in-vitro: A pilot study. Front Oncol. 12(951573)2022.PubMed/NCBI View Article : Google Scholar | |
|
Lu Z, Zhang Y, Yan X, Chen Y, Tao X, Wang J, Jia N, Lyu T, Wang J, Ding J, et al: Estrogen stimulates the invasion of ovarian cancer cells via activation of the PI3K/AKT pathway and regulation of its downstream targets E-cadherin and α-actinin-4. Mol Med Rep. 10:2433–2440. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Liu L, Liu S, Luo H, Chen C, Zhang X, He L and Tu G: GPR30-mediated HMGB1 upregulation in CAFs induces autophagy and tamoxifen resistance in ERα-positive breast cancer cells. Aging (Albany NY). 13:16178–16197. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Johansen JS, Brasso K, Iversen P, Teisner B, Garnero P, Price PA and Christensen IJ: Changes of biochemical markers of bone turnover and YKL-40 following hormonal treatment for metastatic prostate cancer are related to survival. Clin Cancer Res. 13:3244–3249. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Hu X, Wang Q, Zhao H, Wu W, Zhao Q, Jiang R, Liu J, Wang L and Yuan P: Role of miR-21-5p/FilGAP axis in estradiol alleviating the progression of monocrotaline-induced pulmonary hypertension. Animal Model Exp Med. 5:217–226. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Mandel P and Métais P: Les acides nucléiques du plasma sanguin chez l'homme. C R Seances Soc Biol Ses Fil. 142:241–243. 1948.PubMed/NCBI | |
|
Leon SA, Shapiro B, Sklaroff DM and Yaros MJ: Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res. 37:646–650. 1977.PubMed/NCBI | |
|
Schwarzenbach H, Hoon DSB and Pantel K: Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 11:426–437. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, Bartlett BR, Wang H, Luber B, Alani RM, et al: Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 6(224ra24)2014.PubMed/NCBI View Article : Google Scholar | |
|
Kustanovich A, Schwartz R, Peretz T and Grinshpun A: Life and death of circulating cell-free DNA. Cancer Biol Ther. 20:1057–1067. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Wang W, Kong P, Ma G, Li L, Zhu J, Xia T, Xie H, Zhou W and Wang S: Characterization of the release and biological significance of cell-free DNA from breast cancer cell lines. Oncotarget. 8:43180–43191. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Trejo-Becerril C, Pérez-Cárdenas E, Taja-Chayeb L, Anker P, Herrera-Goepfert R, Medina-Velázquez LA, Hidalgo-Miranda A, Pérez-Montiel D, Chávez-Blanco A, Cruz-Velázquez J, et al: Cancer progression mediated by horizontal gene transfer in an in vivo model. PLoS One. 7(e52754)2012.PubMed/NCBI View Article : Google Scholar | |
|
Marsman G, Zeerleder S and Luken BM: Extracellular histones, cell-free DNA, or nucleosomes: Differences in immunostimulation. Cell Death Dis. 7(e2518)2016.PubMed/NCBI View Article : Google Scholar | |
|
Takahashi A, Okada R, Nagao K, Kawamata Y, Hanyu A, Yoshimoto S, Takasugi M, Watanabe S, Kanemaki MT, Obuse C and Hara E: Exosomes maintain cellular homeostasis by excreting harmful DNA from cells. Nat Commun. 8(15287)2017.PubMed/NCBI View Article : Google Scholar | |
|
Pornthanakasem W, Shotelersuk K, Termrungruanglert W, Voravud N, Niruthisard S and Mutirangura A: Human papillomavirus DNA in plasma of patients with cervical cancer. BMC Cancer. 1(2)2001.PubMed/NCBI View Article : Google Scholar | |
|
Guan T, Guo XY, Ye CL and Jiang YH: Analysis of circulating DNA level in the plasma of cervical cancer patients. Nan Fang Yi Ke Da Xue Xue Bao. 28:1663–1664, 1667. 2008.PubMed/NCBI(In Chinese). | |
|
Yang HJ, Liu VWS, Tsang PCK, Yip AMW, Tam KF, Wong LC, Ng TY and Ngan HYS: Quantification of human papillomavirus DNA in the plasma of patients with cervical cancer. Int J Gynecol Cancer. 14:903–910. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Venezuela RF, Kiguen AX, Frutos MC and Cuffini CG: Circulation of human papillomavirus (HPV) genotypes in women from Córdoba, Argentina, with squamous intraepithelial lesions. Rev Inst Med Trop Sao Paulo. 54:11–16. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Campitelli M, Jeannot E, Peter M, Lappartient E, Saada S, de la Rochefordière A, Fourchotte V, Alran S, Petrow P, Cottu P, et al: Human papillomavirus mutational insertion: Specific marker of circulating tumor DNA in cervical cancer patients. PLoS One. 78(e43393)2012.PubMed/NCBI View Article : Google Scholar | |
|
Han K, Leung E, Barbera L, Barnes E, Croke J, Di Grappa MA, Fyles A, Metser U, Milosevic M, Pintilie M, et al: Circulating human papillomavirus DNA as a biomarker of response in patients with locally advanced cervical cancer treated with definitive chemoradiation. JCO Precis Oncol. 2:1–8. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Cabel L, C Bonneau C, Bernard-Tessier A, Héquet D, Tran-Perennial C, Bataillon G, Rouzier R, Féron JG, Fourchotte V, Le Brun JF, et al: HPV ctDNA detection of high-risk HPV types during chemoradiotherapy for locally advanced cervical cancer. ESMO Open. 6(100154)2021.PubMed/NCBI View Article : Google Scholar | |
|
Tian X, Ge D, Zhang F, Zhang B, Bai W, Xu X, Li Z, Cao Y, Li P, Zou K and Zou L: Dynamic analysis of circulating tumor DNA to predict prognosis and monitor therapeutic response in metastatic relapsed cervical cancer. Int J Cancer. 148:921–931. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Fabbri M, Paone A, Calore F, Galli R, Gaudio E, Santhanam R, Lovat F, Fadda P, Mao C, Nuovo GJ, et al: MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci USA. 109:E2110–E2116. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Quillien V, Raoul JL, Laurent JF, Meunier B and Le Prise E: Comparison of Cyfra 21-1, TPA and SCC tumor markers in esophageal squamous cell carcinoma. Oncol Rep. 5:1561–1565. 1998.PubMed/NCBI View Article : Google Scholar | |
|
Bi H, Yin L, Fang W, Song S, Wu S and Shen J: Association of CEA, NSE, CYFRA 21-1, SCC-Ag, and ProGRP with clinicopathological characteristics and chemotherapeutic outcomes of lung cancer. Lab Med: lmac122, 2022 (Epub ahead of print). | |
|
Fatica EM, Larson BJ, Algeciras-Schimnich A and Bornhorst JA: Performance characteristics of the BRAHMS KRYPTOR automated squamous cell carcinoma antigen assay. J Immunol Methods. 504(113257)2022.PubMed/NCBI View Article : Google Scholar | |
|
Petrelli NJ, Shaw N, Bhargava A, Daufeldt J, Herrera L, Stulc JP, Sischy B and Mittelman A: Squamous cell carcinoma antigen as a marker for squamous cell carcinoma of the anal canal. J Clin Oncol. 6:782–785. 1988.PubMed/NCBI View Article : Google Scholar | |
|
Kommu S, Hadway P and Watkin N: Squamous cell carcinoma antigen as a biomarker for penile cancer. BJU Int. 95:478–479. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Huang R, Yao J, Ding X, Liu J, Fan C, Duan H and Ye H: Plasma YKL-40: A potential biomarker for tumor invasion in esophageal cancer. Clin Lab. 66:2020.PubMed/NCBI View Article : Google Scholar | |
|
Tomas C, Risteli J, Risteli L, Stenback F and Kauppila A: Measurement of epithelial and stromal changes in vulvar carcinoma-a clinical, biochemical and immunohistochemical study. Int J Oncol. 7:101–105. 1995.PubMed/NCBI | |
|
Kannan A, Hertweck KL, Philley JV, Wells RB and Dasgupta S: Genetic mutation and exosome signature of human papilloma virus associated oropharyngeal cancer. Sci Rep. 7(46102)2017.PubMed/NCBI View Article : Google Scholar | |
|
Zhang T, Liu Q, Yu M, Lan Y and Zhou J: Expression profiles reveal involvement of VEGF, IGF1, BIRC5, and MMP1 in vulvar carcinogenesis. Technol Cancer Res Treat. 20(15330338211004922)2021.PubMed/NCBI View Article : Google Scholar | |
|
Ramqvist T, Näsman A, Franzén B, Bersani C, Alexeyenko A, Becker S, Haeggblom L, Kolev A, Dalianis T and Munck-Wikland E: Protein expression in tonsillar and base of tongue cancer and in relation to human papillomavirus (HPV) and clinical outcome. Int J Mol Sci. 19(978)2018.PubMed/NCBI View Article : Google Scholar | |
|
Lassig AAD, Joseph AM, Lindgren BR and Yueh B: Association of oral cavity and oropharyngeal cancer biomarkers in surgical drain fluid with patient outcomes. JAMA Otolaryngol Head Neck Surg. 143:670–678. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Emmett SE, Stark MS, Pandeya N, Panizza B, Whiteman DC and Antonsson A: MicroRNA expression is associated with human papillomavirus status and prognosis in mucosal head and neck squamous cell carcinomas. Oral Oncol. 113(105136)2021.PubMed/NCBI View Article : Google Scholar | |
|
Weiss BG, Anczykowski MZ, Ihler F, Bertlich M, Spiegel JL, Haubner F, Canis M, Küffer S, Hess J, Unger K, et al: MicroRNA-182-5p and microRNA-205-5p as potential biomarkers for prognostic stratification of p16-positive oropharyngeal squamous cell carcinoma. Cancer Biomark. 33:331–347. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Zhang J, Liu SC, Luo XH, Tao GX, Guan M, Yuan H and Hu DK: Exosomal long noncoding RNAs are differentially expressed in the cervicovaginal lavage samples of cervical cancer patients. J Clin Lab Anal. 30:1116–1121. 2016.PubMed/NCBI View Article : Google Scholar |
